Andrea Kuendgen

Andrea Kuendgen

UNVERIFIED PROFILE

Are you Andrea Kuendgen?   Register this Author

Register author
Andrea Kuendgen

Andrea Kuendgen

Publications by authors named "Andrea Kuendgen"

Are you Andrea Kuendgen?   Register this Author

46Publications

1182Reads

31Profile Views

Neut-X can be successfully used as diagnostic and prognostic tool in MDS.

Leuk Res 2019 Sep 13;86:106224. Epub 2019 Sep 13.

Universitätsklinikum Düsseldorf, Heinrich-Heine-University, Moorenstr. 5, Düsseldorf, 40225, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.106224DOI Listing
September 2019

A retrospective study evaluating the impact of infectious complications during azacitidine treatment.

Ann Hematol 2017 Jul 4;96(7):1097-1104. Epub 2017 May 4.

Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-3001-2DOI Listing
July 2017

Change of prognosis of patients with myelodysplastic syndromes during the last 30 years.

Leuk Res 2015 Jul 15;39(7):679-83. Epub 2015 Apr 15.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2015.04.001DOI Listing
July 2015

Combining DNA methyltransferase and histone deacetylase inhibition to treat acute myeloid leukemia/myelodysplastic syndrome: achievements and challenges.

Cancer 2015 Feb 21;121(4):498-501. Epub 2014 Oct 21.

Division of Hematology-Oncology, University of Freiburg Medical Center, Freiburg, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.29083
Publisher Site
http://dx.doi.org/10.1002/cncr.29083DOI Listing
February 2015

The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q--new prognostic markers are needed.

Authors:
Andrea Kuendgen

Leuk Res 2014 Mar 26;38(3):287-8. Epub 2013 Dec 26.

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Hospital Duesseldorf, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2013.12.013DOI Listing
March 2014

Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts.

Leuk Res 2013 Jan 31;37(1):64-70. Epub 2012 Oct 31.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2012.09.021DOI Listing
January 2013

An inexpensive way to treat elderly patients with high-risk MDS or AML.

Authors:
Andrea Kuendgen

Leuk Res 2011 Aug 10;35(8):985-6. Epub 2011 May 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.03.026DOI Listing
August 2011

Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.

Eur J Haematol 2009 Nov 22;83(5):477-82. Epub 2009 Jun 22.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University of Duesseldorf, Moorenstrasse 5, D-40225 Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2009.01299.xDOI Listing
November 2009

Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy.

Leuk Res 2009 Sep 9;33(9):1189-93. Epub 2009 May 9.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2009.03.004DOI Listing
September 2009

The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome.

Haematologica 2009 May 31;94(5):729-32. Epub 2009 Mar 31.

Department of Haematology, Oncology and Clinical Immunology Heinrich-Heine-University, Moorenstrasse 5, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2008.002063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675687PMC
May 2009

Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly.

Cancer Treat Rev 2009 Apr 31;35(2):97-120. Epub 2008 Oct 31.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr 5, Düsseldorf 40225, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S030573720800284
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2008.09.001DOI Listing
April 2009

Current status of epigenetic treatment in myelodysplastic syndromes.

Ann Hematol 2008 Aug 5;87(8):601-11. Epub 2008 Apr 5.

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-008-0477-9DOI Listing
August 2008

Valproic acid for the treatment of myeloid malignancies.

Cancer 2007 Sep;110(5):943-54

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22891DOI Listing
September 2007

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.

J Clin Oncol 2007 Aug;25(23):3503-10

Department of Hematology, University of Pavia, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.08.5696DOI Listing
August 2007

Is lenalidomide a new standard treatment for myelodysplastic syndrome?

Authors:
Andrea Kuendgen

Nat Clin Pract Oncol 2007 Jul 15;4(7):396-7. Epub 2007 May 15.

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0823DOI Listing
July 2007

Chronic myelomonocytic leukemia in the light of the WHO proposals.

Haematologica 2007 Jul;92(7):974-7

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.11051DOI Listing
July 2007

Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine.

Leuk Res 2007 Feb 18;31(2):257-9. Epub 2006 Apr 18.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Moorenstr. 5, 40225 Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2006.03.003DOI Listing
February 2007

Differences in epidemiology of MDS between Western and Eastern countries: Ethnic differences or environmental influence?

Leuk Res 2007 Jan 19;31(1):103-4. Epub 2006 Apr 19.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr. 5, 40225 Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014521260600100
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2006.03.007DOI Listing
January 2007

Myelodysplastic syndromes in patients younger than age 50.

J Clin Oncol 2006 Dec 6;24(34):5358-65. Epub 2006 Nov 6.

Department of Hematology, Oncology, and Clinical Immunology, and Institute of Human Genetics, Heinrich-Heine-University, Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.07.5598DOI Listing
December 2006

Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.

Haematologica 2006 Dec;91(12):1596-604

Department of Hematology, Oncology and Clinical Immunology Heinrich-Heine-University Moorenstr. 5, 40225 Düsseldorf, Germany.

View Article

Download full-text PDF

Source
December 2006

Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes.

Blood 2005 Oct 21;106(8):2633-40. Epub 2005 Jun 21.

Division of Hematology, Department of Internal Medicine, Saitama Medical School, 38 Morohongo, Moroyama, Iruma-gun, Saitama, 350-0495, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-01-0040DOI Listing
October 2005

Perspectives in the prognostication of myelodysplastic syndromes.

Haematologica 2005 Sep;90(9):1157-9

View Article

Download full-text PDF

Source
September 2005

Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera.

Ann N Y Acad Sci 2005 Jun;1044:94-108

Klinik für Hämatologie, Onkologie und klinische Immunologie, Heinrich-Heine-Universität Düsseldorf, Moorenstr. 5, D-40225 Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1349.013DOI Listing
June 2005

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid.

Blood 2004 Sep 20;104(5):1266-9. Epub 2004 May 20.

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Moorenstrasse 5, D-40225 Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2003-12-43
Publisher Site
http://dx.doi.org/10.1182/blood-2003-12-4333DOI Listing
September 2004